Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
California would become the first state to block pharmaceutical companies from paying generic competitors to delay the release of lower-priced drugs under a bill announced Wednesday.
Even before Democrats finish drafting bills to create a single-payer health care system, the health care and insurance industries have assembled a small army of lobbyists to kill “Medicare for all,” an idea that is mocked publicly but is being greeted privately with increasing seriousness.
Disease-specific efforts targeting cancer research and efforts to curb HIV in the U.S. will be among the priorities for the Department of Health and Human Services in the year ahead, Secretary Alex Azar said in a speech on Friday.
Two top U.S. senators launched an investigation into rising insulin prices on Friday, sending letters to the three leading manufacturers seeking answers as to why the nearly 100-year-old drug’s cost has rapidly risen, causing taxpayers to spend millions of dollars a year.
When it comes to making changes in health care, CVS Health isn't settling for tinkering around the edges. The company is looking to strike at the heart of how health care is delivered in the U.S.
The Affordable Care Act public exchange system is making a change that could help some people avoid tax nightmares but cause some other people to suffer a sudden, unexpected loss of ACA exchange plan health coverage.
Cigna Corp. officials did everything they could to sabotage a $48.9 billion merger with Anthem Inc., including refusing to consider divestitures that would have helped the deal win regulatory approval, Anthem’s general counsel told a judge.
Several phone apps are sending sensitive user data, including health information, to Facebook without users’ consent, according to a report by The Wall Street Journal.
California Gov. Gavin Newsom says he’s done waiting for the federal government to curtail the rising cost of prescription drugs. Newsom has his own plan to ease that financial burden — one he hopes other states can join or replicate.
There was an itchiness to the relationship between Gavin Newsom, who spent eight years as an understudy, and former Gov. Jerry Brown. Much of it was institutional: California’s lieutenant governor and chief executive don’t run on a joint ticket and once elected, the second in command has almost no official duties. The structure allows even a middling leader to cast an imposing shadow.